Cognition Therapeutics, Inc.
CGTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $25 | $30 | $42 | $55 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $3 | $1 | $4 | $2 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $3 | $2 | $2 |
| Total Curr. Assets | $30 | $34 | $48 | $59 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $2 | $0 |
| Total NC Assets | $1 | $1 | $3 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $30 | $35 | $50 | $59 |
| Liabilities | – | – | – | – |
| Payables | $2 | $4 | $3 | $4 |
| Short-Term Debt | $0 | $1 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $2 | $2 | $1 |
| Other Curr. Liab. | $8 | $4 | $2 | $3 |
| Total Curr. Liab. | $11 | $10 | $8 | $8 |
| LT Debt | $0 | $1 | $1 | $0 |
| Deferred Rev, NC | $0 | $0 | $2 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | -$1 | $0 |
| Other NC Liab. | $0 | $0 | $1 | $0 |
| Total NC Liab. | $0 | $1 | $2 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $0 |
| Total Liabilities | $11 | $11 | $10 | $8 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$175 | -$141 | -$115 | -$94 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $194 | $166 | $156 | $145 |
| Total Equity | $19 | $24 | $40 | $51 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $30 | $35 | $50 | $59 |
| Net Debt | -$24 | -$29 | -$40 | -$55 |